Navigation Links
Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
Date:10/21/2008

CUMBERLAND, R.I., Oct. 21 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced today the opening of its new 27,000 square-foot GMP manufacturing facility in Cumberland, Rhode Island.

With support from the Rhode Island Economic Development Corporation (RIEDC) and its financing programs, Rhode Island Industrial Facilities Corporation (RIIFC) and Rhode Island Industrial-Recreational Building Authority (IRBA), Neurotech was approved for a $4 million financing to help pay for the cost of equipping this facility.

The Company's lead development program is NT-501 for the treatment of Retinitis Pigmentosa (RP) and the dry form of age-related macular degeneration (dry AMD). NT-501 is an intraocular, cell containing polymer implant designed to provide continuous, long-term release of the therapeutic protein Ciliary Neurotrophic Factor (CNTF) directly into the back of the eye by means of the Company's proprietary Encapsulated Cell Technology. CNTF, a well established neurotrophic factor, rescues dying retinal photoreceptors and protects them from degeneration.

"We are extremely pleased to locate our manufacturing facility in Cumberland, RI and to have the support of the State in helping us equip the facility," said Ted Danse, President and CEO of Neurotech. "Due to the State's support we were able to finance the costs of the manufacturing equipment at a very attractive cost of capital. We are looking forward in continuing to work with the State as we continue to develop our unique technology and expand our infrastructure."

"High tech manufacturing in the biotechnology industry is a critical component of our economic development and job growth strategy," said Governor Donald L. Carcieri. "I commend Neurotech for their commitment to expand operations and create new job opportunities here in Rhode Island, and am pleas
'/>"/>

SOURCE Neurotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ORIMtec Releases Industry's First Intraoperative Monitoring Reference Guide for Neurotechnologists
2. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
3. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
4. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
5. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
6. Laureate Announces Manufacturing Agreement with Tolerx
7. Amgen Announces Webcast of 2008 Third Quarter Financial Results
8. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
9. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
10. RSCI Announces Two Additions to Its Science Advisory Board, Calling for More Stem Cell Research on Diabetes
11. ADVENTRX Announces Restructuring and Cost Reduction Initiatives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
(Date:11/24/2009)...ovember 24 Shire plc (LS...pharmaceutical company, today,announced that it ha... for,velaglucerase alfa, the company,s enzyme repl...f Type 1 Gaucher disease. This is the third market...en submitted, with previous,submissions in the Uni...
(Date:11/24/2009)...Italy, November 24 Health Robotics... joint venture with a group of selected,investors....perate under the,name Health Robotics Canada, Inc....tics, i.v. Room of the Future concept, which inclu...N(TM), i.v.SOFT(TM), and OMM(TM).,Health Robotics ...
(Date:11/24/2009)...ov. 24 Cell Therapeutics...l present at the 21st Annual Piper Jaffray Health ...ber 1-2, 2009, at the New York Palace Hotel. ,...0 a.m. Eastern Time in Holmes 1 (4th Floor). A liv...lable at www.celltherapeutics.com , and it will a...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...E, Fla., July 30 Bioheart, Inc.,(Nasdaq: BHRT ) ...ces and,biologics that help monitor, diagnose and ...oday announced financial results for the second,qu...ights:, -- On July 24, 2008, we announced that th...ection of myoblasts modified to express stromal,de...
...ute focuses on science education, SAN DIEGO, July...on focused on advancing science literacy, has secu...to serve as a bridge between learning,institutions...tial $30,000 grants from the Pfizer Foundation and...(c) (3) arm of BIOCOM, the,association for the Sou...
...AUDERDALE, Fla., July 30 For years, a part of the...n the potential health,hazards of electromagnetic ...pidemiology study ever conducted over cell phone u...y from Northern Europe, the pioneers of,the wirele...se of cancer,risks has been reported, especially f...
Other Biology Technology:Bioheart, Inc. Announces Financial Results for Second Quarter 2008 2Bioheart, Inc. Announces Financial Results for Second Quarter 2008 3Bioheart, Inc. Announces Financial Results for Second Quarter 2008 4Bioheart, Inc. Announces Financial Results for Second Quarter 2008 5Bioheart, Inc. Announces Financial Results for Second Quarter 2008 6Bioheart, Inc. Announces Financial Results for Second Quarter 2008 7BIOCOM Institute Secures Non-Profit Designation and Funding 2BIOCOM Institute Secures Non-Profit Designation and Funding 3Wireless Devices May Be at Fault for Certain Health Risks 2
(Date:11/24/2009)...ORK (November 24, 2009) -- The Wildlife Conservati...g that the last remaining population of Siberian t... rising tide of poaching and habitat loss. , ...ian officials of what needs to be done to protect ... , The report was released by the Si...
(Date:11/23/2009)...h presents strong evidence that the "synergistic" ...fic-related pollution and indoor endotoxin causes ...r exposure alone. , Environmental health scien... of Medicine have shown that children exposed to b...ndoor endotoxin during early life are six times mo...
(Date:11/23/2009)...e than 160 participants gathered this week for the...ITIATIVE conference. This year,s topic, "Synthetic... and medical researchers to explore the engineerin...merging field of synthetic biology. , Bonnie L. ...on University and this year,s conference chair, ch...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27 2009 55188 1Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27 2009 55188 2Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 1Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 2Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 3Risky Business 3A New Study Explores Role of Gender Testosterone in Financial Risk Aversion 55183 4MRI Might Find Early Alzheimers 55180 1MRI Might Find Early Alzheimers 55180 2
...e the first pandemic in the early 19th century it ...erner from The Hebrew University of Jerusalem, Isr...ly infamous insect: chironomids (midges). Lerner e... with the deadly bacteria when laying their eggs. ...ir Broza had found that females actively choose th...
...s of researchers, one in the United States and one...ew optical techniques for visualizing the invisibl... published results are the first to showcase the O...ing (ISP) initiative, which allows authors to subm...nal data and gives researchers, scientists and eng...
...2008) The world,s rarest big cat is alive and wel...searchers from the Wildlife Conservation Society (...n leopard in Russia last week., The capture was m...rder by a team of scientists from WCS and the Russ...oils (IBS). The team is evaluating the health and...
Other Biology News:Polarized light guides cholera-carrying midges that contaminate water supplies 2OSA's ISP launches with research on breathing disorders and congenital heart defects 2OSA's ISP launches with research on breathing disorders and congenital heart defects 3OSA's ISP launches with research on breathing disorders and congenital heart defects 4World's rarest big cat gets a check-up 2World's rarest big cat gets a check-up 3
...ndard microarray image analysis software because o...ools, visualizations, automation capabilities, per...with every GenePix scanner, and it also imports TI...of arrays. A wide range of spot finding and analys...
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, Floppy Disk from PerkinElmer
Human CALCA EIA (Enzyme immunoassay) Kit, Host: Rabbit ; Extraction-free from BACHEM
...through in accurate, small-volume bulk dispensing....olution, the micro 1 has unique advantages not fou... 1 never needs re-calibration as do other 1mL disp... an LCD Display , Graphical Row Selection , 96-,38...
Biology Products: